DR. LELAND C SMITH M.D. NPI 1508084807

NPI Details

DR. Leland C Smith, M.D. is a dermatology in Oak Ridge, TN with 17 years of experience. The provider is a dermatologist is trained to diagnose and treat pediatric and adult patients with benign and malignant disorders of the skin, mouth, external genitalia, hair and nails, as well as a number of sexually transmitted diseases. The dermatologist has had additional training and experience in the diagnosis and treatment of skin cancers, melanomas, moles and other tumors of the skin, the management of contact dermatitis and other allergic and nonallergic skin disorders, and in the recognition of the skin manifestations of systemic (including internal malignancy) and infectious diseases. Dermatologists have special training in dermatopathology and in the surgical techniques used in dermatology. They also have expertise in the management of cosmetic disorders of the skin such as hair loss and scars and the skin changes associated with aging. DR. Leland C Smith, M.D. NPI is 1508084807. The provider is registered as an individual entity type.

The NPPES NPI record indicates the provider is a male.

Education
Medical School: UNIVERSITY OF TENNESSEE, HSC, COLLEGE OF MEDICINE
Graduation Year:2009

The provider's business location address is:

599 OAK RIDGE TPKE
OAK RIDGE, TN
ZIP 37830-177
Phone: (865) 483-2568
Fax: (865) 482-4036

The NPI 1508084807 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

• Destruction of precancer skin growth, 2-14 growths (HCPCS:17003)
• Destruction of precancer skin growth, 1 growth (HCPCS:17000)
• Established patient office or other outpatient visit, 20-29 minutes (HCPCS:99213)
• Established patient office or other outpatient visit, 10-19 minutes (HCPCS:99212)
• Biopsy of related skin growth, first growth (HCPCS:11102)
• Destruction of skin growth, 1-14 growths (HCPCS:17110)
• Destruction of cancer skin growth of trunk, arms, or legs, 0.6-1.0 cm (HCPCS:17261)
• Biopsy of related skin growth, each additional growth (HCPCS:11103)
• Destruction of cancer skin growth of trunk, arms, or legs, 1.1-2.0 cm (HCPCS:17262)
• Intermediate repair of wound of face, ears, eyelids, nose, lips, or mouth, 2.6-5.0 cm (HCPCS:12052)
• Removal of cancer skin growth of face, ears, eyelids, nose, lips, or mouth, 1.1-2.0 cm (HCPCS:11642)
• Destruction of precancer skin growth, 15 or more growths (HCPCS:17004)
• Intermediate repair of wound of scalp, underarms, trunk, arms, or legs, 2.6-7.5 cm (HCPCS:12032)
• New patient office or other outpatient visit, 30-44 minutes (HCPCS:99203)
• Removal of cancer skin growth of face, ears, eyelids, nose, lips, or mouth, 0.6-1.0 cm (HCPCS:11641)
• Punch biopsy, first skin growth (HCPCS:11104)
• Destruction of cancer skin growth of face, ears, eyelids, nose, lips, or mouth, 0.6-1.0 cm (HCPCS:17281)
• Destruction of cancer skin growth of scalp, neck, hands, feet, or genitals, 0.6-1.0 cm (HCPCS:17271)
• Established patient office or other outpatient visit, 30-39 minutes (HCPCS:99214)
• Intermediate repair of wound of face, ears, eyelids, nose, lips, or mouth, 2.5 cm or less (HCPCS:12051)
• Destruction of cancer skin growth of scalp, neck, hands, feet, or genitals, 1.1-2.0 cm (HCPCS:17272)
• Removal of cancer skin growth of scalp, neck, hands, feet, or genitals, 1.1-2.0 cm (HCPCS:11622)
• Removal of cancer skin growth of body, arms, or legs, 1.1-2.0 cm (HCPCS:11602)
• Destruction of cancer skin growth of face, ears, eyelids, nose, lips, or mouth, 0.5 cm or less (HCPCS:17280)
• New patient office or other outpatient visit, 15-29 minutes (HCPCS:99202)
• Intermediate repair of wound of neck, hands, feet, or genitals, 2.6-7.5 cm (HCPCS:12042)
• Injection, triamcinolone acetonide, not otherwise specified, 10 mg (HCPCS:J3301)
• Aminolevulinic acid hcl for topical administration, 20%, single unit dosage form (354 mg) (HCPCS:J7308)
• Removal of cancer skin growth of body, arms, or legs, 2.1-3.0 cm (HCPCS:11603)
• Destruction of cancer skin growth of trunk, arms, or legs, 0.5 cm or less (HCPCS:17260)
• Application of light to destroy precancer skin growth (HCPCS:96567)
• All potassium hydroxide (koh) preparations (HCPCS:Q0112)
• Removal of noncancer skin growth of body, arms, or legs, 0.6-1.0 cm (HCPCS:11401)
• Intermediate repair of wound of scalp, underarms, trunk, arms, or legs, 7.6-12.5 cm (HCPCS:12034)
• Intermediate repair of wound of scalp, underarms, trunk, arms, or legs, 2.5 cm or less (HCPCS:12031)
• Injection into skin growth, 1-7 growths (HCPCS:11900)
• Destruction of cancer skin growth of trunk, arms, or legs, 2.1-3.0 cm (HCPCS:17263)
• Intermediate repair of wound of face, ears, eyelids, nose, lips, or mouth, 5.1-7.5 cm (HCPCS:12053)
• Biopsy of ear (HCPCS:69100)
• Removal of noncancer skin growth of body, arms, or legs, 1.1-2.0 cm (HCPCS:11402)
• Melanoma (skin cancer) excision (HCPCS:NAN03)

The enumeration date for this NPI number is 4/23/2007 and was last updated on 10/30/2025.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available: